| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 2,712,000 | 2,666,000 | 2,615,000 | 2,357,000 | | Cost of Revenue | (1,424,000) | 2,158,000 | 2,004,000 | 1,929,000 | | | Gross Profit | 4,136,000 | 508,000 | 611,000 | 428,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,815,000 | 324,000 | 338,000 | 328,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 154,000 | 162,000 | 150,000 | 150,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 167,000 | 22,000 | 123,000 | (50,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 58,000 | 1,000 | 27,000 | (19,000) | | Earnings Before Interest And Taxes | 225,000 | 23,000 | 150,000 | (69,000) | | Interest Expense | 41,000 | 43,000 | 43,000 | 38,000 | | Income Before Tax | 184,000 | (20,000) | 107,000 | (107,000) | | Income Tax Expense | 69,000 | (4,000) | 16,000 | (16,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 115,000 | (16,000) | 91,000 | (91,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 115,000 | (16,000) | 91,000 | (91,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $115,000 | ($16,000) | $91,000 | ($91,000) |
|
0.75% Nasdaq 
Income Statement
